These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1021227)

  • 21. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.
    Swain SM; Sorace RA; Bagley CS; Danforth DN; Bader J; Wesley MN; Steinberg SM; Lippman ME
    Cancer Res; 1987 Jul; 47(14):3889-94. PubMed ID: 3036348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer.
    Lerner HJ; Band PR; Israel L; Leung BS
    Cancer Treat Rep; 1976 Oct; 60(10):1431-5. PubMed ID: 798626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
    Kosmidis PA; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
    Chemioterapia; 1987 Dec; 6(6):393-5. PubMed ID: 3435921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
    Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of adriamycin in advanced and recurrent breast cancer (No. 4)--Joint study by 30 institutes on the duration of remission using various maintenance therapies in patients treated with CAF. Clinical Study Group of Adriamycin for Breast Cancer in Japan].
    Nomura Y; Abe O; Izuo M; Inoue K; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1863-71. PubMed ID: 3382238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
    Kaufmann M; Graf E; Jonat W; Eiermann W; Geberth M; Albert US; Gademann G; Conrad B; Stahl K; von Minckwitz G; Schumacher M;
    J Clin Oncol; 2005 Nov; 23(31):7842-8. PubMed ID: 16258087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic combination chemotherapy for metastatic breast cancer.
    Biran S; Krasnokuki D; Hochman A; Brufman G
    Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of tamoxifen dose in advanced breast cancer: a progress report.
    Tormey DC; Simon RM; Lippman ME; Bull JM; Myers CE
    Cancer Treat Rep; 1976 Oct; 60(10):1451-9. PubMed ID: 1021226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 31. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormone therapy and chemotherapy of breast cancer].
    Heuson JC; Mattheiem WH
    Brux Med; 1976 Dec; 56(12):489-95. PubMed ID: 189879
    [No Abstract]   [Full Text] [Related]  

  • 33. Increasing the response rate to cytotoxic chemotherapy by endocrine means.
    Lippman ME; Cassidy J; Wesley M; Young RC
    J Steroid Biochem; 1985 Dec; 23(6B):1173-80. PubMed ID: 3005774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.
    Kolarić K; Roth A; Vukas D; Cervek J
    Cancer Chemother Pharmacol; 1984; 13(2):142-4. PubMed ID: 6380789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-oestrogen treatment of metastasising carcinoma of the breast (author's transl)].
    Henningsen B; Amberger H
    Dtsch Med Wochenschr; 1977 May; 102(19):713-6. PubMed ID: 870301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy with or without tamoxifen in postmenopausal patients with late breast cancer. A randomized study.
    Boccardo F; Rubagotti A; Rosso R; Santi L
    J Steroid Biochem; 1985 Dec; 23(6B):1123-7. PubMed ID: 3912616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy in primary and metastatic intrathoracic cancer].
    Mannes P; Derriks R; Moens R; Laurent C
    Ann Med Interne (Paris); 1976 Jan; 127(1):25-34. PubMed ID: 1008360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficiency and side effects of adriamycin-cyclophosphamide therapy compared to a triple combination of cyclophosphamide, methotrexate and 5-fluoro-uracil].
    Weymar P; Schulz KD; Noldus B; Schmidt-Rhode P
    Arch Gynecol; 1979 Jul; 228(1-4):445-6. PubMed ID: 485425
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.
    Metz R; Delgado M; Keiling R; Cappelaere P; Armand JP; Prevot G; Misset JL; Grimbert J; Mathe G
    Invest New Drugs; 1985; 3(2):163-6. PubMed ID: 4019119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
    Hoogstraten B; George SL; Samal B; Rivkin SE; Costanzi JJ; Bonnet JD; Thigpen T; Braine H
    Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.